Chapter 568 Physiology of the Adrenal Gland
568.1 Histology and Embryology
Several transcription factors are critical for the development of the adrenal glands. The three that are associated with adrenal hypoplasia in humans are steroidogenic factor-1 (SF-1; NR5A1), DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia congenita, X chromosome; NR0B1), and the GLI3 oncogene. Disruption of SF-1, encoded on chromosome 9q33, results in gonadal and often adrenal agenesis, absence of pituitary gonadotropes, and an underdeveloped ventral medial hypothalamus. In-frame deletions and frameshift and missense mutations of this gene are associated with 46,XX ovarian insufficiency and 46,XY gonadal dysgenesis. Mutations in the DAX1 gene, encoded on Xp21, result in adrenal hypoplasia congenita and hypogonadotropic hypogonadism (Chapter 569.1). Mutations in GLI3 on chromosome 7p13 cause Pallister-Hall syndrome, other features of which include hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly. Postnatally, both SF-1 and DAX-1 play important roles in regulating steroidogenesis by modulating transcription of steroidogenic enzymes.
Ferraz-de-Souza B, Achermann JC. Disorders of adrenal development. Endocr Dev. 2008;13:19-32.
Hammer GD, Parker KL, Schimmer BP. Minireview: transcriptional regulation of adrenocortical development. Endocrinology. 2005;146:1018-1024.
Kempna P, Fluck CE. Adrenal gland development and defects. Best Pract Res Clin Endocrinol Metab. 2008;22:77-93.
Lourenco D, Brauner R, Lin L, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009;360:1200-1210.
568.2 Adrenal Steroid Biosynthesis
Cholesterol is the starting substrate for all steroid biosynthesis (see Fig. 568-1 on the Nelson Textbook of Pediatrics website at www.expertconsult.com). Although adrenal cortex cells can synthesize cholesterol de novo from acetate, circulating plasma lipoproteins provide most of the cholesterol for adrenal cortex hormone formation. Receptors for both low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol are expressed on the surface of adrenocortical cells; the receptor is termed scavenger receptor class B, type I (SR-BI). Patients with familial hypercholesterolemia who lack LDL receptors have unimpaired adrenal steroidogenesis, suggesting that HDL is the more important source of cholesterol. Cholesterol is stored as cholesteryl esters in vesicles and subsequently hydrolyzed by cholesteryl ester hydrolases to liberate free cholesterol for steroid hormone synthesis.
Zona Fasciculata
In the endoplasmic reticulum of the zona fasciculata, pregnenolone and progesterone are converted by 17α-hydroxylase (P450c17, CYP17) to 17-hydroxypregenolone and 17-hydroxyprogesterone, respectively. This enzyme is not expressed in the zona glomerulosa, which consequently cannot synthesize 17-hydroxylated steroids. 17-Hydroxypregnenolone is converted to 17-hydroxyprogesterone and 11-deoxycortisol by the same 3β-hydroxysteroid and 21-hydroxylase enzymes, respectively, as are active in the zona glomerulosa. Thus, inherited disorders in these enzymes affect both aldosterone and cortisol synthesis (Chapter 570). Finally, 11-deoxycortisol reenters mitochondria and is converted to cortisol by steroid 11β-hydroxylase (P450c11, CYP11B1). This enzyme is closely related to aldosterone synthase but has low 18-hydroxylase and nonexistent 18-oxidase activity. Thus, under normal circumstances the zona fasciculata cannot synthesize aldosterone.
Fetoplacental Unit
Steroid synthesis in the fetal adrenal varies during gestation (Figs. 568-1 and 568-2). Shortly after the fetal adrenal gland forms (wk 8-10), it efficiently secretes cortisol, which is able to negatively feed back on the fetal pituitary and hypothalamus to suppress ACTH secretion. This is critical time for differentiation of the external genitalia in both sexes (Chapter 570.1); to prevent virilization, the female fetus must not be exposed to high levels of androgens of adrenal origin, and placental aromatase activity must remain low during this time to minimize conversion of testosterone to estradiol in male fetuses, which would interfere with masculinization. After wk 12, HSD3B activity in the fetal adrenal gland decreases and steroid sulfokinase activity increases. Thus, the major steroid products of the midgestation fetal adrenal gland are DHEA and DHEA sulfate (DHEAS) and, by 16α-hydroxylation in the liver, 16α-hydroxy DHEAS. Aromatase activity increases in the placenta at the same time, and steroid sulfatase activity is high as well. Thus, the placenta uses DHEA and DHEAS as substrates for estrone and estradiol and 16α-OH DHEAS as a substrate for estriol. Cortisol activity is low during the 2nd trimester, which might serve to prevent premature secretion of surfactant by the developing fetal lungs; surfactant levels can affect the timing of parturition. As term approaches, fetal cortisol concentration increases as a result of increased cortisol secretion and decreased conversion of cortisol to cortisone by 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2). Low levels of aldosterone are produced in mid gestation, but aldosterone secretory capacity increases near term.